Works matching IS 00221899 AND DT 2014 AND VI 210 AND IP 3


Results: 31
    1
    2
    3
    4
    5
    6
    7

    Cover.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 3, p. NP, doi. 10.1093/infdis/jiu387
    Publication type:
    Article
    8

    Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 3, p. 354, doi. 10.1093/infdis/jiu051
    By:
    • Castagna, Antonella;
    • Maggiolo, Franco;
    • Penco, Giovanni;
    • Wright, David;
    • Mills, Anthony;
    • Grossberg, Robert;
    • Molina, Jean-Michel;
    • Chas, Julie;
    • Durant, Jacques;
    • Moreno, Santiago;
    • Doroana, Manuela;
    • Ait-Khaled, Mounir;
    • Huang, Jenny;
    • Min, Sherene;
    • Song, Ivy;
    • Vavro, Cindy;
    • Nichols, Garrett;
    • Yeo, Jane M.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Editorial Board.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 3, p. NP, doi. 10.1093/infdis/jit720
    Publication type:
    Article
    18
    19
    20
    21
    22

    Masthead.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 3, p. NP, doi. 10.1093/infdis/jit744
    Publication type:
    Article
    23
    24
    25

    Subscriptions Page.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 3, p. NP, doi. 10.1093/infdis/jit768
    Publication type:
    Article
    26
    27

    Editorial Advisory Board.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 3, p. NP, doi. 10.1093/infdis/jit696
    Publication type:
    Article
    28
    29
    30
    31